Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.120
-0.040 (-3.45%)
Jun 24, 2026, 4:00 PM EDT - Market closed
Tiziana Life Sciences Employees
Tiziana Life Sciences had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$1,843,100
Market Cap
143.53M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 10 | 1 | 11.11% |
| Dec 31, 2024 | 9 | 0 | - |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | -5 | -35.71% |
| Dec 31, 2021 | 14 | 3 | 27.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADC Therapeutics | 193 |
| Molecular Partners AG | 134 |
| Fractyl Health | 100 |
| Alpha Cognition | 71 |
| Tenaya Therapeutics | 70 |
| Corbus Pharmaceuticals Holdings | 36 |
| Enlivex | 34 |
| Cognition Therapeutics | 14 |
TLSA News
- 9 days ago - Tiziana Life Sciences chairman Gabriele Cerrone purchases 15,000 shares - TheFly
- 9 days ago - Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman - GlobeNewsWire
- 27 days ago - Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York - GlobeNewsWire
- 4 weeks ago - Tiziana fully enrolls Phase 2 placebo-controlled MS trial - TheFly
- 4 weeks ago - Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial - GlobeNewsWire
- 5 weeks ago - Tiziana Life Sciences announces updated intranasal foralumab data - TheFly
- 5 weeks ago - Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis - GlobeNewsWire
- 5 weeks ago - Tiziana Phase 2 trial for foralumab shows reduced brain inflammation - TheFly